Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIGEST: S-1 + Cisplatin in Metastatic Diffuse Gastric Cancer
NCT01285557Phase 3Terminated
- Sponsor
- Taiho Oncology
- Start
- Apr 2011
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of tegafur in gastric cancer (GC), sponsored by Taiho Oncology. Started Apr 2011; status: terminated.
02
Drugs
tegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01285557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01285557.